2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine

C10H14F3N3 — CID 164662603

IUPAC2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine
SMILESFC(F)(F)CNCc1cc2n(n1)CCCC2
InChIInChI=1S/C10H14F3N3/c11-10(12,13)7-14-6-8-5-9-3-1-2-4-16(9)15-8/h5,14H,1-4,6-7H2
InChIKeyADOSOXSFHSHMOJ-UHFFFAOYSA-N
MW233.24 g/mol
LogP1.87
Rot. Bonds3

About 2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine

2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine (PubChem CID 164662603) has the molecular formula C10H14F3N3 and a molecular weight of 233.24 g/mol. Its IUPAC name is 2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine.

Molecular Properties

Compound Name2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine
PubChem CID164662603
Molecular FormulaC10H14F3N3
Molecular Weight233.24 g/mol
Exact Mass233.11
IUPAC Name2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine
SMILESFC(F)(F)CNCc1cc2n(n1)CCCC2
InChIInChI=1S/C10H14F3N3/c11-10(12,13)7-14-6-8-5-9-3-1-2-4-16(9)15-8/h5,14H,1-4,6-7H2
InChIKeyADOSOXSFHSHMOJ-UHFFFAOYSA-N
XLogP1.87
TPSA29.85 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds3
Heavy Atoms16
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500233.24
LogP ≤ 51.87
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Analyze 2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4,5,6,7-Tetrahydro-2-(trifluoromethyl)-pyrazolo(1,5-a)pyrazine
CID 54775461
2-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine dihydrochloride
CID 73012568
4H,5H,6H,7H-pyrazolo[1,5-a]pyridin-4-amine
CID 83872256
2-cyclopropyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine hydrochloride
CID 132286794
2-[[4-(Trifluoromethyl)piperidin-1-yl]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine
CID 56915169
1,3-dimethyl-5-(pyrrolidin-2-yl)-1H-pyrazole
CID 25248066
2-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)ethan-1-amine
CID 71833007
methyl({[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]methyl})amine hydrochloride
CID 90486250
1-{4H,5H,6H,7H-pyrazolo[1,5-a]pyridin-2-yl}ethan-1-amine dihydrochloride
CID 122149390
(4H,5H,6H,7H-pyrazolo(1,5-a)pyridin-2-yl)methanamine dihydrochloride
CID 122156683
2-tert-butyl-4H,5H,6H,7H-pyrazolo(1,5-a)pyrazine hydrochloride
CID 132300870
2-methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine hydrochloride
CID 132353952

Frequently Asked Questions

What is the IUPAC name of 2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine?
The IUPAC name of 2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine (CID 164662603) is 2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine.
What is the SMILES notation for 2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine?
The canonical SMILES for 2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine is FC(F)(F)CNCc1cc2n(n1)CCCC2.
What is the InChIKey of 2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine?
The InChIKey is ADOSOXSFHSHMOJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C10H14F3N3/c11-10(12,13)7-14-6-8-5-9-3-1-2-4-16(9)15-8/h5,14H,1-4,6-7H2.
What are the key properties of 2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine?
2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine has a molecular weight of 233.24 g/mol, XLogP of 1.87, 3 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 2,2,2-trifluoro-N-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-ylmethyl)ethanamine is sourced from PubChem (CID 164662603), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).